Patents by Inventor Bryan B. Fuller

Bryan B. Fuller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180235859
    Abstract: Compositions containing an effective dermatological disease-treating or dermatological condition-treating active agent and a pharmaceutically-acceptable carrier or vehicle are disclosed. Methods of using the compositions are also disclosed.
    Type: Application
    Filed: April 25, 2018
    Publication date: August 23, 2018
    Inventor: Bryan B. Fuller
  • Patent number: 9980887
    Abstract: Compositions containing an effective dermatological disease-treating or dermatological condition-treating active agent and a pharmaceutically-acceptable carrier or vehicle are disclosed. Methods of using the compositions are also disclosed.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: May 29, 2018
    Assignee: DermaMedics, LLC
    Inventor: Bryan B. Fuller
  • Patent number: 9622950
    Abstract: Compositions containing an effective dermatological disease-treating or dermatological condition-treating active agent and a pharmaceutically-acceptable carrier or vehicle are disclosed.
    Type: Grant
    Filed: June 17, 2013
    Date of Patent: April 18, 2017
    Assignee: DermaMedics, LLC
    Inventor: Bryan B. Fuller
  • Patent number: 9616006
    Abstract: The presently claimed and disclosed inventive concept(s) contemplates compositions comprising compounds, in particular dihydroeugenol (DHE) and/or isoeugenol (IE) and/or ethyl vanillin (EV) or salts, esters, ethers, or derivatives thereof, and methods for topically or systemically delivering them for treatment against inflammation-related and other dermatological conditions such as described herein. These DHE and/or IE and/or EV or salts, esters, ethers or derivatives thereof also are delivered to a measurable extent transepidermally or transdermally.
    Type: Grant
    Filed: March 31, 2010
    Date of Patent: April 11, 2017
    Assignee: DermaMedics, LLC
    Inventor: Bryan B. Fuller
  • Publication number: 20160346180
    Abstract: Compositions containing an effective dermatological disease-treating or dermatological condition-treating active agent and a pharmaceutically-acceptable carrier or vehicle are disclosed. Methods of using the compositions are also disclosed.
    Type: Application
    Filed: August 15, 2016
    Publication date: December 1, 2016
    Inventor: Bryan B. Fuller
  • Publication number: 20130289006
    Abstract: Compositions are disclosed that contain an effective hyperpigmentation-treating active agent and a pharmaceutically-acceptable carrier or vehicle. Methods of using the compositions to treat hyperpigmentation are also disclosed.
    Type: Application
    Filed: June 17, 2013
    Publication date: October 31, 2013
    Inventor: Bryan B. Fuller
  • Publication number: 20130281411
    Abstract: Compositions are disclosed that contain an effective inflammatory-dermatological disease-treating or condition-treating active agent and a pharmaceutically-acceptable carrier or vehicle. Methods of using the compositions to treat a subject's skin are also disclosed.
    Type: Application
    Filed: June 17, 2013
    Publication date: October 24, 2013
    Inventor: Bryan B. Fuller
  • Publication number: 20130280195
    Abstract: Compositions containing an effective dermatological disease-treating or dermatological condition-treating active agent and a pharmaceutically-acceptable carrier or vehicle are disclosed. Methods of using the compositions are also disclosed.
    Type: Application
    Filed: June 17, 2013
    Publication date: October 24, 2013
    Inventor: Bryan B. Fuller
  • Publication number: 20130274231
    Abstract: Compositions containing an effective dermatological disease-treating or dermatological condition-treating active agent and a pharmaceutically-acceptable carrier or vehicle are disclosed.
    Type: Application
    Filed: June 17, 2013
    Publication date: October 17, 2013
    Inventor: Bryan B. Fuller
  • Publication number: 20100249244
    Abstract: The presently claimed and disclosed inventive concept(s) contemplates compositions comprising compounds, in particular dihydroeugenol (DHE) and/or isoeugenol (IE) and/or ethyl vanillin (EV) or salts, esters, ethers, or derivatives thereof, and methods for topically or systemically delivering them for treatment against inflammation-related and other dermatological conditions such as described herein. These DHE and/or IE and/or EV or salts, esters, ethers or derivatives thereof also are delivered to a measurable extent transepidermally or transdermally.
    Type: Application
    Filed: March 31, 2010
    Publication date: September 30, 2010
    Inventor: Bryan B. Fuller
  • Patent number: 6110448
    Abstract: A method and composition for the topical application of a yohimbine or derivative or stereoisomer thereof, or effective .alpha..sub.2 -antagonists, skin for inhibiting melanogenesis in the skin leading to skin lightening. The yohimbine may be provided as a natural extract, for example, as an extract of Johimbe bark. The composition may include a skin exfoliant.
    Type: Grant
    Filed: March 5, 1999
    Date of Patent: August 29, 2000
    Assignee: The Board of Regents of the University of Oklahoma
    Inventor: Bryan B. Fuller
  • Patent number: 6096295
    Abstract: A method and composition for the topical application of a yohimbine or derivative or stereoisomer thereof, or effective .alpha..sub.2 -antagonists to skin for inhibiting melanogenesis in the skin leading to skin lightening. The yohimbine may be provided as a natural extract, for example, as an extract of Johimbe bark. The composition may include a skin exfoliant.
    Type: Grant
    Filed: March 5, 1999
    Date of Patent: August 1, 2000
    Assignee: The Board of Regents of the University of Oklahoma
    Inventor: Bryan B. Fuller
  • Patent number: 5989576
    Abstract: A method and composition for the topical application of a yohimbine or derivative or stereoisomer thereof or effective .alpha..sub.2 -antagonists, to the skin for inhibiting melanogenesis in the skin leading to skin lightening. The yohimbine may be provided as a natural extract, for example, as an extract of Johimbe bark.
    Type: Grant
    Filed: December 17, 1998
    Date of Patent: November 23, 1999
    Assignee: The Board of Regents of the University of Oklahoma
    Inventor: Bryan B. Fuller
  • Patent number: 5919436
    Abstract: A method and composition for the topical application of a yohimbine or derivative or stereoisomer thereof or effective .alpha..sub.2 -antagonists, to the skin for inhibiting melanogenesis in the skin leading to skin lightening. The yohimbine may be provided as a natural extract, for example, as an extract of Johimbe bark.
    Type: Grant
    Filed: September 25, 1997
    Date of Patent: July 6, 1999
    Assignee: The Board of Regents of the University of Oklahoma
    Inventor: Bryan B. Fuller
  • Patent number: 5905091
    Abstract: A composition comprising a carrier and prostaglandin effective in stimulating synthesis of melanin in a human melanocyte thereby enhancing pigmentation of the human skin and optionally comprising a lysosomotropic agent, a phosphodiesterase inhibitor, and/or methylxanthines, and a method of use of the composition. Use of this composition promotes tanning of the human skin and increases photoprotection from ultraviolet radiation.
    Type: Grant
    Filed: July 1, 1997
    Date of Patent: May 18, 1999
    Assignee: The Board of Regents of The University of Oklahoma
    Inventor: Bryan B. Fuller
  • Patent number: 5879665
    Abstract: A method and composition for the topical application of a yohimbine or derivative or stereoisomer thereof, or effective .alpha..sub.2 -antagonists, skin for inhibiting melanogenesis in the skin leading to skin lightening. The yohimbine may be provided as a natural extract, for example, as an extract of Johimbe bark.
    Type: Grant
    Filed: September 25, 1997
    Date of Patent: March 9, 1999
    Assignee: The Board of Regents of The University of Oklahoma
    Inventor: Bryan B. Fuller
  • Patent number: 5628987
    Abstract: A composition for increasing synthesis of melanin in a human melanocyte thereby enhancing pigmentation of the human skin. Use of this composition promotes tanning of the human skin and increases photoprotection from ultraviolet radiation. An organ culture system comprising viable human foreskin samples which may be used to test the effects of agents on human skin, including pigmentation enhancers on human skin.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: May 13, 1997
    Assignee: The Board of Regents of the University of Oklahoma
    Inventor: Bryan B. Fuller
  • Patent number: 5591423
    Abstract: A composition for increasing synthesis of melanin in a human melanocyte thereby enhancing pigmentation of the human skin. Use of this composition promotes tanning of the human skin and increases photoprotection from ultraviolet radiation. An organ culture system comprising viable human foreskin samples which may be used to test the effects of agents on human skin, including pigmentation enhancers on human skin.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: January 7, 1997
    Assignee: The Board of Regents of the University of Oklahoma
    Inventor: Bryan B. Fuller
  • Patent number: 5589161
    Abstract: A composition for increasing synthesis of melanin in a human melanocyte thereby enhancing pigmentation of the human skin. Use of this composition promotes tanning of the human skin and increases photoprotection from ultraviolet radiation. An organ culture system comprising viable human foreskin samples which may be used to test the effects of agents on human skin, including pigmentation enhancers on human skin.
    Type: Grant
    Filed: September 8, 1994
    Date of Patent: December 31, 1996
    Assignee: The Board of Regents of the University Oklahoma
    Inventor: Bryan B. Fuller
  • Patent number: 5554359
    Abstract: A composition comprising a lysosomotropic agent, and optionally phosphodiesterase inhibitors, and/or methylxanthines for increasing synthesis of melanin in a human melanocyte thereby enhancing pigmentation of the human skin. Use of this composition promotes tanning of the human skin and increases photoprotection from ultraviolet radiation. An organ culture system comprising viable human foreskin samples which may be used to test the effects of agents on human skin, including pigmentation enhancers on human skin.
    Type: Grant
    Filed: May 31, 1994
    Date of Patent: September 10, 1996
    Assignee: The Board of Regents of the University of Oklahoma
    Inventor: Bryan B. Fuller